Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|115-121

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 115-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

By  

Oncology, Vol. 80, Iss. 3-4, 2011-07 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Chemotherapy for soft tissue sarcoma

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2952-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 333-338

Karger

Access to resources Recommend Favorite

Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma

By  

Cardiology in the Young, Vol. 27, Iss. 9, 2017-08 ,pp. : 1815-1822

Cambridge University Press

Access to resources Recommend Favorite

Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite